Skip to main content
Premium Trial:

Request an Annual Quote

Cypher Genomics Taps BioBase to Help with Genomic Data Interpretation


BioBase said this week that Cypher Genomics has selected its GenomeTrax database solution to help with interpreting genomic variants in next-generation sequencing data.

Cypher Genomics offers NGS analysis services for medical geneticists, computational biologists, clinicians, and researchers. BioBase’s Genome Trax lets users prioritize human genome variants in whole genome or exome data for further investigation. It also identifies novel mutations that are likely to affect the function of candidate disease genes, and enables users to filter out the millions of irrelevant variants.

According to BioBase, researchers at Cypher Genomics will incorporate data from Genome Trax’s knowledgebase into their variant analysis pipeline.

It “frees them to focus on their deep expertise in computer science, quantitative genetics, and medicine, to deliver state-of-the-art genome processing to their customers," Frank Schacherer, BioBase’s chief technology officer, said in a statement.

Genome Trax “provides the most comprehensive database of human disease associations," Ali Torkamani, Cypher Genomics’ chief science officer, said in a statement. It “is an invaluable resource in both clinical and research-grade genetics and genomics activities.”

Other recent Genome Trax customers include the Luxembourg Center for Systems Biomedicine, which is using the software to analyze next-generation sequencing data for use in clinical diagnostics (BI 7/20/2012).

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.